L-Cin OZ Tablet

Ornidazole, a nitroimidazole derivative, is effective against anaerobic bacteria and protozoa by disrupting DNA synthesis and causing strand breakage. This synergistic combination is particularly useful in managing infections involving both aerobic and anaerobic pathogens, such as intra-abdominal infections, pelvic inflammatory disease, gastrointestinal infections, and certain respiratory tract infections.

L-Cin OZ Tablet is indicated where polymicrobial infections are suspected or confirmed, providing comprehensive antimicrobial coverage. The medication should be administered as prescribed, with consideration of patient-specific factors including renal function and potential drug interactions. Adverse effects may include gastrointestinal disturbances, headache, dizziness, and hypersensitivity reactions.

Caution is advised in patients with a history of hypersensitivity to fluoroquinolones or nitroimidazoles, and use during pregnancy and lactation should be under strict medical supervision. Appropriate microbiological diagnosis and susceptibility testing are recommended to ensure optimal therapeutic outcomes.